Ennapadam S Venkatraman
Overview
Explore the profile of Ennapadam S Venkatraman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamada Y, Bilsky M, Lovelock D, Venkatraman E, Toner S, Johnson J, et al.
Int J Radiat Oncol Biol Phys
. 2008 Feb;
71(2):484-90.
PMID: 18234445
Purpose: To report tumor control and toxicity for patients treated with image-guided intensity-modulated radiotherapy (RT) for spinal metastases with high-dose single-fraction RT. Methods And Materials: A total of 103 consecutive...
2.
Sarkaria I, Zakowski M, Pham D, Hezel M, Ebright M, Chuai S, et al.
Ann Thorac Surg
. 2007 Dec;
85(1):216-23.
PMID: 18154814
Background: Epidermal growth factor receptor (EGFR) has gained importance in non-small cell lung cancer given impressive responses to agents targeting this molecule, particularly in bronchioloalveolar carcinoma (BAC) and adenocarcinomas, mixed...
3.
Lee N, Chan K, Bekelman J, Zhung J, Mechalakos J, Narayana A, et al.
Int J Radiat Oncol Biol Phys
. 2007 Mar;
68(3):731-40.
PMID: 17379449
Purpose: To present a retrospective review of treatment outcomes for recurrent head and neck (HN) cancer patients treated with re-irradiation (re-RT) at a single medical center. Methods And Materials: From...
4.
Lee N, de Arruda F, Puri D, Wolden S, Narayana A, Mechalakos J, et al.
Int J Radiat Oncol Biol Phys
. 2006 Dec;
66(4):966-74.
PMID: 17145527
Purpose: The aim of this study was to compare toxicity/efficacy of conventional radiotherapy using delayed accelerated concomitant boost radiotherapy (CBRT) vs. intensity-modulated radiotherapy (IMRT) in the setting of concurrent chemotherapy...
5.
Zelefsky M, Ben-Porat L, Chan H, Fearn P, Venkatraman E
Int J Radiat Oncol Biol Phys
. 2006 Sep;
66(2):382-8.
PMID: 16965990
Purpose: To describe the prostate-specific antigen (PSA) pattern profiles observed after external beam radiotherapy with and without short-term neoadjuvant androgen deprivation therapy (ST-ADT) and to report the association of established...
6.
Chi D, McCaughty K, Diaz J, Huh J, Schwabenbauer S, Hummer A, et al.
Cancer
. 2006 Mar;
106(9):1933-9.
PMID: 16572412
Background: The benefit of cytoreductive surgery for patients with recurrent epithelial ovarian cancer has not been defined clearly. The objective of this study was to identify prognostic factors for survival...
7.
Pham D, Kris M, Riely G, Sarkaria I, McDonough T, Chuai S, et al.
J Clin Oncol
. 2006 Mar;
24(11):1700-4.
PMID: 16505411
Purpose: Lung adenocarcinomas with mutations in exons 19 and 21 of the epidermal growth factor receptor gene (EGFR) demonstrate sensitivity to gefitinib or erlotinib. Investigators have reported an association between...
8.
Riely G, Pao W, Pham D, Li A, Rizvi N, Venkatraman E, et al.
Clin Cancer Res
. 2006 Feb;
12(3 Pt 1):839-44.
PMID: 16467097
Purpose: In patients with non-small cell lung cancer (NSCLC), mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain have been associated with sensitivity to erlotinib and gefitinib. We...
9.
McCreath W, Eisenhauer E, Abu-Rustum N, Venkatraman E, Caceres A, Bier R, et al.
Gynecol Oncol
. 2006 Jan;
102(1):8-14.
PMID: 16427689
Objective: The objective of this study was to identify independent prognostic factors for survival in patients with epithelial ovarian cancer who had persistent disease identified at second-look surgery. Methods: We...
10.
Mourton S, Chi D, Sonoda Y, Alektiar K, Venkatraman E, Barakat R, et al.
Gynecol Oncol
. 2005 Oct;
100(3):533-6.
PMID: 16226800
Objectives: To determine the incidence and prognostic implications of positive mesorectal lymph nodes in patients undergoing total pelvic exenteration for recurrent gynecologic malignancies. Methods: We performed a retrospective chart review...